Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SIBN
SIBN logo

SIBN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy SI-BONE Inc (SIBN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
15.840
1 Day change
4.14%
52 Week Range
21.890
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

SI-BONE Inc (SIBN) is not an immediate buy for a beginner investor with a long-term strategy. While the company shows positive growth potential and hedge funds are buying, the lack of strong proprietary trading signals, neutral insider activity, and mixed technical indicators suggest waiting for a better entry point.

Technical Analysis

The MACD is positively expanding, indicating bullish momentum. RSI is neutral at 69.046, and moving averages are converging, showing no clear trend. Key resistance levels are at 15.825 and 16.086, while support levels are at 14.98 and 14.719.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
12

Positive Catalysts

  • Hedge funds are significantly increasing their holdings, with a 457520.97% increase in buying over the last quarter. Analysts maintain a Buy rating, citing strong Q1 results with solid gross margins and EBITDA beat. Revenue guidance has been raised.

Neutral/Negative Catalysts

  • No recent news or significant insider activity. Analysts have lowered price targets due to peer group multiple compression. Technical indicators and candlestick patterns suggest limited short-term upside potential.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a Buy rating but have lowered price targets from $20-$24 to $18 due to market conditions. They highlight strong Q1 results and expect growth to accelerate.

Wall Street analysts forecast SIBN stock price to rise
6 Analyst Rating
Wall Street analysts forecast SIBN stock price to rise
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 15.210
sliders
Low
23
Averages
25.17
High
28
Current: 15.210
sliders
Low
23
Averages
25.17
High
28
Truist
Richard Newitter
Buy
downgrade
$20 -> $18
AI Analysis
2026-05-12
Reason
Truist
Richard Newitter
Price Target
$20 -> $18
AI Analysis
2026-05-12
downgrade
Buy
Reason
Truist analyst Richard Newitter lowered the firm's price target on SI-Bone to $18 from $20 and keeps a Buy rating on the shares. The firm notes that its reduced price target reflects a lower multiple as the company's peer group has experienced multiple compression, though it is also positive on the company's good Q1 results with solid gross margins and EBITDA beat, the analyst tells investors in a research note.
TD Cowen
Mathew Blackman
Buy
downgrade
$22 -> $18
2026-05-12
Reason
TD Cowen
Mathew Blackman
Price Target
$22 -> $18
2026-05-12
downgrade
Buy
Reason
TD Cowen analyst Mathew Blackman lowered the firm's price target on SI-Bone to $18 from $22 and keeps a Buy rating on the shares. The firm said sales and EBITDA beat expectations and growth should accelerate from here. Revenue guidance was raised just below the 1Q beat at the midpoint, but they attribute this more to FX/conservatism rather than anything one-off.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SIBN
Unlock Now

People Also Watch